ReviewExpert opinion on pharmacotherapy2017

Degarelix versus luteinizing hormone-releasing hormone agonists for the treatment of prostate cancer.

Timothy N Clinton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.